First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Maße
Höhe: 216 mm
Breite: 138 mm
Gewicht
ISBN-13
978-0-415-81562-8 (9780415815628)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
John Braithwaite
Autor*in
Australian National University, ACT, Australia
Preface 1. Introduction: an industry case study of corporate crime 2. Bribery 3. Safety testing of drugs: from negligence to fraud 4. Unsafe manufacturing practices 5. Antitrust 6. The corporation as pusher 7. Drug companies and the Third World 8. Fiddling 9. Strategies for controlling corporate crime; Appendix: Getting interviews with corporate executives; Notes; Bibliography; Index